
2019-nCOV IgG/IgM RAPID TEST
Introducing Rapid Tests to Measure IgM and IgG Antibodies to the SARS-CoV-2 Virus
SSI Diagnostica A/S is the exclusive distributor in the Nordics of antibody tests from CTK Biotech.
The tests are intended for the presumptive qualitative detection of IgM and IgG antibodies to the SARS-CoV-2 virus in patients suspected of a COVID-19 infection.
COVID-19 IgG/IgM Rapid Tests detects anti-SARS-CoV-2 IgG and IgM antibodies in human serum, plasma or whole blood.
The tests can be performed within 15 minutes without the use of time consuming laboratory equipment.
Simple One-step Test with Rapid Results*

- Rapid results – read after 15 minutes
- Easy to interpret results
- No additional equipment or training needed
- For human plasma, serum or whole blood
* See Instruction For Use for each specific product
Performance of Antibody Tests
See how the three antibody tests performed in a recent evaluation conducted in Denmark.1

https://forskning.ruc.dk/da/publications/evaluation-of-nine-commercial-sars-cov-2-immunoassays
The actual report can be downloaded at the bottom of the page, or you can get in contact with us and learn more.
When to Measure IgG/IgM Antibodies
IgM antibodies are generated initially by the body as a result of infection at about the time symptoms appear.
The rapid test result depends on the time of infection.
IgM immune response is present after 5 days after infection, and will increase over time. Given that IgM is a marker of early infection.2
Highest IgG immune response is seen 14 days after infection.2
Determine Immunity with Rapid Antibody Tests
- Determine seroprevalence in a given population
- Define previous exposure
1. RUC (2020): Evaluation of nine commercial SARS-CoV-2 Immunoassays
2. Guo, L. ET. Al; (2020): Clinical Infectious Diseases, https://academic.oup.com/cid/article/71/15/778/5810754